Wexford Capital »

Alpine Immune Sciences shares owned by Wexford Capital

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Wexford Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $916k 23k 39.64

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
Cenovus Energy (CVE)
International Seaways (INSW)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Crescent Point Energy Trust (CPG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Total Stk Mkt (VTI)
Daqo New Energy Corp Spnsrd Ads New (DQ)
Coca-cola Femsa Sab De Cv Sponsord Adr Rep (KOF)
Nephros (NEPH)
Enterprise Products Partners (EPD)
Energy Transfer Com Ut Ltd Ptn (ET)
Evergy (EVRG)
Avis Budget (CAR)
PG&E Corporation (PCG)

View all positions for Wexford Capital

Top funds holding Alpine Immune Sciences

Decheng Capital
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Franklin Resources

View all funds holding Alpine Immune Sciences